UBS Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.08M | Buy |
|
|||||
|
2025
Q2 | $1.59M | Sell |
|
|||||
|
2025
Q1 | $2.18M | Buy |
|
|||||
|
2024
Q4 | $2.14M | Buy |
|
|||||
|
2024
Q3 | $579K | Sell |
|
|||||
|
2024
Q2 | $723K | Sell |
|
|||||
|
2024
Q1 | $1.34M | Sell |
|
|||||
|
2023
Q4 | $1.19M | Buy |
|
|||||
|
2023
Q3 | $689K | Sell |
|
|||||
|
2023
Q2 | $1.4M | Buy |
|
|||||
|
2023
Q1 | $845K | Buy |
|
|||||
|
2022
Q4 | $402K | Buy |
|
|||||
|
2022
Q3 | $193K | Buy |
|
|||||
|
2022
Q2 | $36K | Sell |
|
|||||
|
2022
Q1 | $217K | Sell |
|
|||||
|
2021
Q4 | $336K | Buy |
|
|||||
|
2021
Q3 | $49K | Sell |
|
|||||
|
2021
Q2 | $188K | Sell |
|
|||||
|
2021
Q1 | $465K | Sell |
|
|||||
|
2020
Q4 | $566K | Buy |
|
|||||
|
2020
Q3 | $199K | Sell |
|
|||||
|
2020
Q2 | $262K | Sell |
|
|||||
|
2020
Q1 | $304K | Sell |
|
|||||
|
2019
Q4 | $693K | Buy |
|
|||||
|
2019
Q3 | $470K | Buy |
|
|||||
|
2019
Q2 | $89K | Buy |
|
|||||
|
2019
Q1 | $38K | Sell |
|
|||||
|
2018
Q4 | $189K | Sell |
|
|||||
|
2018
Q3 | $348K | Buy |
|
|||||
|
2018
Q2 | $280K | Sell |
|
|||||
|
2018
Q1 | $539K | Sell |
|
|||||
|
2017
Q4 | $683K | Sell |
|
|||||
|
2017
Q3 | $882K | Buy |
|
|||||
|
2017
Q2 | $712K | Buy |
|
|||||
|
2017
Q1 | $145K | Sell |
|
|||||
|
2016
Q4 | $196K | Buy |
|
|||||
|
2016
Q3 | $77K | Sell |
|
|||||
|
2016
Q2 | $60K | Buy |
|
|||||
|
2016
Q1 | $60K | Buy |
|
|||||
|
2015
Q4 | $50K | Sell |
|
|||||
|
2015
Q3 | $61K | Buy |
|
|||||
|
2015
Q2 | $35K | Sell |
|
|||||
|
2015
Q1 | $24K | Buy |
|
|||||
|
2014
Q4 | $22K | Buy |
|